|
Online CME Activity
The Cost of Cancer Care: Issues Facing Oncologists and Their Patients
|
NOTE: Although this activity is no longer certified for credit, we believe that it contains important information and hope you’ll review, print or email it to a colleague.
The Cost of Cancer Care: Issues Facing Oncologists and Their Patients
1.00 AMA PRA Category 1 Credits™
Learning Objective
Identify the economic, social, and emotional factors that are likely to play a role when it is necessary for oncologists to discuss the costs of cancer care with their patients.
Accreditation
Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with Pri-Med Institute's Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of Pri-Med Institute.
| Credits |
Type |
Accreditation Statement |
Designation Statement |
| 1.00 |
AMA PRA Category 1 Credits™ |
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
Pri-Med Institute designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
Faculty and Editorial Board
Written By:
Deborah Schrag, MD, MPH, Associate Professor of Medicine, Harvard Medical School, Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, Massachusetts
Edited By:
Kate Rouhana, Pri-Med
Financial Disclosure Statement(s)
Dr Schrag has no financial relationships to disclose.
The content collaborators at Dana-Farber Cancer Institute have no financial relationships to disclose.
Ms Fitzgerald has no financial relationships to disclose.
Education Partner:
Dana-Farber Cancer Institute
Pri-Med Disclaimer
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, M|C Communications, LLC, or the Dana-Farber Cancer Institute.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
|
|
|
